These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


402 related items for PubMed ID: 17673010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 4. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.
    Pneumonol Alergol Pol; 2002 Sep; 70(3-4):193-202. PubMed ID: 12271966
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [Abstract] [Full Text] [Related]

  • 7. Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997.
    Abe C, Hirano K, Wada M, Aoyagi T.
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):46-52. PubMed ID: 11263516
    [Abstract] [Full Text] [Related]

  • 8. [Surveillance of drug resistant tuberculosis in Hubei, China].
    Li G, Wu X, Zhang T, Zhou L, Li K, Liu X, Li A, Dai X, Yuan F.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):723-6. PubMed ID: 12622890
    [Abstract] [Full Text] [Related]

  • 9. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 10. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G, González J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PR, Escaramís G, Ascaso C, García A, Jiménez de Anta MT.
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [Abstract] [Full Text] [Related]

  • 11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 12. Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002.
    Tuberculosis Research Committee (Ryoken).
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1129-35. PubMed ID: 17945071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

  • 15. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V, Arnadottir T, Laticevschi D.
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [Abstract] [Full Text] [Related]

  • 16. [Primary and acquired drug resistance of tuberculosis bacilli in Poland].
    Zofia Z, Ewa AK, Magdalena K.
    Pneumonol Alergol Pol; 1999 Apr; 67(11-12):536-45. PubMed ID: 11057104
    [Abstract] [Full Text] [Related]

  • 17. [The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China].
    Shen X, Shen M, Gui XH, Gao Q, Mei J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):407-10. PubMed ID: 17673008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
    Hasan R, Jabeen K, Mehraj V, Zafar F, Malik F, Hassan Q, Azam I, Kadir MM.
    Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103
    [Abstract] [Full Text] [Related]

  • 20. Relatively low primary resistance to anti-tuberculosis drugs in Bangui and Bimbo, Central African Republic.
    Minime-Lingoupou F, Manirakiza A, Yango F, Zandanga G, Le Faou A, Rigouts L.
    Int J Tuberc Lung Dis; 2011 May; 15(5):657-61. PubMed ID: 21756518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.